Delivery Order SPE2DB22D9309-SPE2DB24FAE87
Award Date
5/8/24
Potential Completion Date
5/30/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of EXPAREL 133 MG/10 ML VIAL 10ML. This $1,427.82 contract award is part of a larger $499,999,999 indefinite delivery contract (IDC) vehicle under the DLA's SPE2DB program, which enables the agency to fulfill recurring pharmaceutical supply needs of military health facilities worldwide. DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide EXPAREL 266 MG/20 ML VIAL 20ML. This $49,744.40 delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group to fulfill recurring pharmaceutical supply needs for military health facilities worldwide. The IDC, which runs through December 31, 2025, allows the DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The order has a potential value of $2,487.22 and a completion date of February 12, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to support military treatment facilities worldwide under...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $11,422.56, has a completion date of February 5, 2024. This award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles with DLA to supply a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of EXPAREL 1.3% 20ML 10S. The contract, valued at $14,923.32, has a completion date of May 16, 2024 and is not set aside. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a wide range of pharmaceutical products...
The Defense Logistics Agency (DLA) awarded a $9,948.88 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product, with a period of performance through December 2, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to deliver EXPAREL 266 MG/20 ML VIAL 20ML. The firm fixed-price contract has a potential value of $29,846.64 and a completion date of March 7, 2024. This delivery order is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, which enables DLA to issue orders for a wide range...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563452317 EXPAREL 133 MG/10 ML VIAL 10ML. The order has a completion date of February 9, 2024 and a potential value of $3,437.04. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with the Defense Logistics Agency to supply a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,923.32 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group with DLA. The IDV contract, valued at up to $4,999,999, enables DLA to issue delivery orders for a broad range of pharmaceutical products to support...